| Glutathione GSH, L-Glutathione | FDA Approved | Longevity | Moderate | Generally Recognized as Safe (GRAS). Available as dietary supplement; IV formulations used clinically. |
| HMG Human Menopausal Gonadotropin, Menotropins | FDA Approved | Hormonal | High | FDA-approved (Menopur) for assisted reproduction. |
| Human Chorionic Gonadotropin (hCG) hCG, Choriogonadotropin | FDA Approved | Hormonal | High | FDA-approved (Pregnyl, Ovidrel) for fertility treatment. |
| Liraglutide Victoza, Saxenda | FDA Approved | Metabolic | High | FDA-approved as Victoza (T2D) and Saxenda (weight management). |
| Melanotan-1 Afamelanotide, Scenesse | FDA Approved | Other | Moderate | FDA-approved October 2019 (NDA 210797) as Scenesse for the prevention of phototoxicity in adults with EPP. EMA-approved ... |
| Pasireotide SOM230, Signifor | FDA Approved | Hormonal | High | FDA-approved as Signifor for Cushing's disease and acromegaly. |
| PT-141 Bremelanotide, Vyleesi | FDA Approved | Hormonal | High | FDA-approved as Vyleesi (bremelanotide) for hypoactive sexual desire disorder in premenopausal women. |
| Semaglutide Ozempic, Wegovy | FDA Approved | Metabolic | High | FDA-approved as Ozempic (T2D), Wegovy (weight management), and Rybelsus (oral T2D). Compounded versions restricted since... |
| Tesamorelin Egrifta, Egrifta SV | FDA Approved | Hormonal | High | FDA-approved as Egrifta for HIV-associated lipodystrophy. |
| Tirzepatide LY3298176, Mounjaro | FDA Approved | Metabolic | High | FDA-approved as Mounjaro (T2D) and Zepbound (weight management). Compounded versions restricted since 2024. |
| 225Ac-DOTA-LM3 Actinium-225-DOTA-LM3, 225Ac-DOTA-JR11 | Investigational | Other | Moderate | Phase 1/2 clinical trials for prostate cancer. Alpha-emitting PSMA-targeting radiopharmaceutical. |
| Alixorexton ALKS 2680, ALKS-2680 | Investigational | Cognitive | Moderate | Phase 1 clinical trials (Novo Nordisk). Next-gen metabolic candidate. |
| Amycretin NNC0487-0111, Oral Amycretin | Investigational | Metabolic | Moderate | Phase 2 clinical trials for obesity (Novo Nordisk). Oral GLP-1/amylin dual agonist. |
| BT5528 Bicycle Toxin Conjugate 5528, EphA2-BTC | Investigational | Other | Moderate | Phase 1/2 clinical trials for solid tumors (Bicycle Therapeutics). EphA2-targeting bicycle toxin conjugate. |
| Cagrilintide AM833, NN9838 | Investigational | Metabolic | High | Phase 3 as part of CagriSema combination (Novo Nordisk). Long-acting amylin analog. |
| CagriSema Cagrilintide-Semaglutide, NNC0174-0833 | Investigational | Metabolic | High | Phase 3 clinical trials for obesity (Novo Nordisk). Cagrilintide + semaglutide combination. |
| CT-388 RG-6912 | Investigational | Metabolic | Moderate | Phase 2 clinical trials for obesity (Carmot Therapeutics/Roche). GLP-1/GIP dual agonist. |
| EVX-01 EVX01, Evaxion EVX-01 | Investigational | Other | Moderate | Phase 1 clinical trials for cancer (Evaxion Biotech). AI-designed personalized cancer vaccine. |
| MariTide AMG 133, maridebart cafraglutide | Investigational | Metabolic | Moderate | Phase 2 clinical trials for obesity (Amgen). GLP-1/GIPR antagonist combination. |
| Mazdutide IBI362, LY3305677 | Investigational | Metabolic | High | Phase 3 clinical trials for obesity and T2D (Innovent Biologics). GLP-1/glucagon dual agonist. |
| mRNA-4157/V940 V940, mRNA-4157 | Investigational | Other | High | Phase 3 clinical trials for melanoma (Moderna). Personalized mRNA cancer vaccine, used with pembrolizumab. |
| Murepavadin POL7080, RG7929 | Investigational | Immune | Moderate | Clinical trials for Pseudomonas aeruginosa infections. Outer membrane protein-targeting antibiotic peptide. |
| Orforglipron LY3502970, OWL833 | Investigational | Metabolic | High | Phase 3 clinical trials for obesity and T2D (Eli Lilly). Oral non-peptide GLP-1 agonist. |
| Oveporexton TAK-861 | Investigational | Cognitive | Moderate | Phase 1 clinical trials for obesity (Novo Nordisk). Next-gen anti-obesity candidate. |
| Pemvidutide ALT-801, GLP-1/Glucagon Dual Agonist | Investigational | Metabolic | Moderate | Phase 2 clinical trials for obesity and MASH (Altimmune). GLP-1/glucagon dual agonist. |
| Retatrutide LY3437943, GGG Triple Agonist | Investigational | Metabolic | High | Phase 3 clinical trials for obesity and T2D (Eli Lilly). Triple agonist (GLP-1/GIP/glucagon). |
| SS-31 Elamipretide, Bendavia | Investigational | Longevity | Moderate | Phase 3 clinical trials as elamipretide for mitochondrial diseases (Stealth BioTherapeutics). |
| Sulanemadlin ALRN-6924, MP-4897 | Investigational | Other | Moderate | Phase 2 clinical trials for solid tumors. MDM2 inhibitor reactivating p53. |
| Survodutide BI 456906, BI-456906 | Investigational | Metabolic | High | Phase 3 clinical trials for obesity and MASH (Boehringer Ingelheim). GLP-1/glucagon dual agonist. |
| VK2735 Viking 2735 | Investigational | Metabolic | Moderate | Phase 2 clinical trials for obesity (Viking Therapeutics). GLP-1/GIP dual agonist. |
| Zelenectide Pevedotin BT8009, Bicycle Drug Conjugate BT8009 | Investigational | Other | Moderate | Phase 1 clinical trials for solid tumors. Antibody-drug conjugate. |
| 5-Amino-1MQ 5-Amino-1-Methylquinolinium, NNMT Inhibitor | Research Only | Metabolic | Low | Not FDA-approved. Small molecule NNMT inhibitor. Preclinical research on metabolism and fat loss. |
| Alpha-Defensins HNP-1, HNP-2 | Research Only | Immune | Moderate | Not FDA-approved as therapeutics. Naturally occurring antimicrobial peptides. Preclinical research. |
| AOD-9604 Anti-Obesity Drug 9604, Tyr-hGH Fragment 177-191 | Research Only | Metabolic | Low | Not FDA-approved. Fragment of human growth hormone (hGH 176-191). Phase 2 trials for obesity showed limited efficacy. |
| BPC-157 Body Protection Compound-157, Bepecin | Research Only | Recovery | Low | Not FDA-approved. Extensive preclinical research but no completed human clinical trials. Available through compounding p... |
| Bronchogen AEDL, Ala-Glu-Asp-Leu | Research Only | Other | Low | Not FDA-approved. Khavinson bioregulator peptide for bronchial tissue. Available in Russia. |
| Cardiogen AED, Ala-Glu-Asp | Research Only | Other | Low | Not FDA-approved. Khavinson bioregulator peptide for cardiovascular tissue. Available in Russia. |
| Cartalax AED peptide, Ala-Glu-Asp | Research Only | Recovery | Low | Not approved by any regulatory agency. Classified as a research peptide. Part of Khavinson's bioregulator framework deve... |
| Cerebrolysin FPF-1070, N-PEP-12 | Research Only | Cognitive | Moderate | Not FDA-approved in US. Approved in 45+ countries for stroke and dementia. Porcine brain-derived peptide mixture. |
| Cerluten Brain cytamin, Cerebral peptides | Research Only | Cognitive | Low | Not FDA-approved. Khavinson bioregulator peptide for brain tissue. Available in Russia. |
| Chonluten EDG-GI, Glu-Asp-Gly (GI) | Research Only | Other | Low | Not FDA-approved. Khavinson bioregulator peptide for respiratory mucosa. Available in Russia. |
| CJC-1295 DAC:GRF, Modified GRF 1-29 | Research Only | Hormonal | Moderate | Not FDA-approved. Modified GHRH analog. Limited clinical research; widely used in anti-aging clinics. |
| Cortexin Cortexinum, Polypeptide brain extract | Research Only | Cognitive | Moderate | Not FDA-approved in US. Approved in Russia for neurological conditions. Brain-derived peptide complex. |
| Dihexa PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide | Research Only | Cognitive | Very-low | Not FDA-approved. Angiotensin IV analog. Preclinical research on cognitive enhancement. |
| DSIP Delta Sleep Inducing Peptide, Delta Sleep-Inducing Peptide | Research Only | Cognitive | Moderate | Not FDA-approved. Delta sleep-inducing peptide. Limited and conflicting research results. |
| Endoluten Pineal cytamin, Pineal gland peptides | Research Only | Longevity | Low | Not FDA-approved. Khavinson bioregulator peptide for pineal gland. Available in Russia. |
| Epithalon Epitalon, Epithalone | Research Only | Longevity | Low | Not FDA-approved. Synthetic tetrapeptide studied for telomerase activation. Developed by Prof. Khavinson; limited clinic... |
| Follistatin FST, FS-344 | Research Only | Hormonal | Moderate | Not FDA-approved. Naturally occurring glycoprotein. Preclinical research on muscle growth and fibrosis. |
| FOXO4-DRI FOXO4-D-Retro-Inverso, FOXO4-DRI Peptide | Research Only | Longevity | Very-low | Not FDA-approved. Senolytic peptide. Preclinical research only; studied for selective clearance of senescent cells. |
| GHK Glycyl-Histidyl-Lysine, GHK tripeptide | Research Only | Recovery | Moderate | Not FDA-approved. Naturally occurring tripeptide. Extensive in-vitro and animal research on wound healing and skin repai... |
| GHK-Cu Copper Peptide GHK, Glycyl-L-Histidyl-L-Lysine:Copper | Research Only | Recovery | Moderate | Not FDA-approved. Copper-bound GHK peptide. Available in cosmetic formulations. Preclinical research on tissue repair. |
| GHRP-2 Growth Hormone Releasing Peptide-2, Pralmorelin | Research Only | Hormonal | Moderate | Not FDA-approved. Growth hormone releasing peptide. Limited clinical research. |
| GHRP-6 Growth Hormone Releasing Peptide-6, SKF-110679 | Research Only | Hormonal | Moderate | Not FDA-approved. Growth hormone releasing peptide. Limited clinical research. |
| Hexarelin Examorelin, HEX | Research Only | Hormonal | Moderate | Not FDA-approved. Growth hormone secretagogue. Limited clinical research, some cardioprotective studies. |
| Humanin HN, HNG | Research Only | Longevity | Moderate | Not FDA-approved. Mitochondrial-derived peptide. Preclinical research on neuroprotection and metabolic health. |
| IGF-1 LR3 Long R3 IGF-1, LR3-IGF-1 | Research Only | Hormonal | Low | Not FDA-approved. Modified IGF-1 analog. Note: natural IGF-1 (mecasermin/Increlex) is FDA-approved for growth failure. |
| Ipamorelin NNC 26-0161, NNC-26-0161 | Research Only | Hormonal | Moderate | Not FDA-approved. Growth hormone releasing peptide. Preclinical and limited clinical research. |
| Kisspeptin KISS1, Metastin | Research Only | Hormonal | Moderate | Not FDA-approved. Naturally occurring neuropeptide. Active research in reproductive endocrinology. |
| KPV Lys-Pro-Val, Lysine-Proline-Valine | Research Only | Immune | Low | Not FDA-approved. Tripeptide fragment of alpha-MSH. Preclinical research on anti-inflammatory effects. |
| Kristagen EDG, Glu-Asp-Gly | Research Only | Immune | Low | Not FDA-approved. Khavinson bioregulator peptide for immune system. Available in Russia. |
| Lactoferricin LFcinB, Lactoferricin B | Research Only | Immune | Low | Not FDA-approved. Antimicrobial peptide derived from lactoferrin. Preclinical research on antimicrobial and anticancer p... |
| Livagen KED, Lys-Glu-Asp | Research Only | Other | Low | Not FDA-approved. Khavinson bioregulator peptide for liver tissue. Available in Russia. |
| LL-37 Cathelicidin, hCAP18 | Research Only | Immune | Moderate | Not FDA-approved. Human cathelicidin antimicrobial peptide. Preclinical research on infection and wound healing. |
| Melanotan II MT-II, MT-2 | Research Only | Other | Moderate | Not FDA-approved. Research peptide for tanning/sexual dysfunction. Significant safety concerns; not recommended for huma... |
| MK-677 Ibutamoren, Ibutamoren Mesylate | Research Only | Hormonal | Moderate | Not FDA-approved. Oral growth hormone secretagogue (ibutamoren). Phase 2 trials completed but development discontinued. |
| MOTS-c Mitochondrial ORF of the 12S rRNA type-c, Mitochondrial-derived peptide | Research Only | Longevity | Low | Not FDA-approved. Mitochondrial-derived peptide. Preclinical research on metabolism and exercise mimetics. |
| N-Acetyl Selank Amidate NA-Selank, N-Acetyl Selank | Research Only | Cognitive | Very-low | Not FDA-approved. Modified form of selank. Research compound only. |
| N-Acetyl Semax Amidate NA-Semax, N-Acetyl Semax | Research Only | Cognitive | Very-low | Not FDA-approved. Modified form of semax. Research compound only. |
| Ovagen EDL, Glu-Asp-Leu | Research Only | Other | Low | Not FDA-approved. Khavinson bioregulator peptide for liver and GI tract. Available in Russia. |
| P21 Ac-DGGLAG-NH2, P021 | Research Only | Cognitive | Very-low | Not FDA-approved. Synthetic peptide fragment of CNTF. Preclinical research on neurogenesis. |
| Pancragen KEDW, Lys-Glu-Asp-Trp | Research Only | Other | Low | Not FDA-approved. Khavinson bioregulator peptide for pancreatic tissue. Available in Russia. |
| Pinealon EDR, Glu-Asp-Arg | Research Only | Cognitive | Low | Not FDA-approved. Khavinson bioregulator peptide for brain tissue. Synthetic tripeptide. |
| Prostatilen Prostate peptide extract, Samprost | Research Only | Hormonal | Moderate | Not FDA-approved in US. Approved in Russia for prostate conditions. Bovine prostate-derived peptide. |
| Retinalamin Retinal peptide complex, Eye peptide | Research Only | Other | Moderate | Not FDA-approved in US. Approved in Russia for retinal conditions. Bovine retina-derived peptide. |
| Selank TP-7, Selanc | Research Only | Cognitive | Moderate | Not FDA-approved in US. Approved in Russia as an anxiolytic. Synthetic analog of tuftsin. |
| Semax ACTH(4-7)PGP, Methionyl-Glutamyl-Histidyl-Phenylalanyl-Prolyl-Glycyl-Proline | Research Only | Cognitive | Moderate | Not FDA-approved in US. Approved in Russia for stroke recovery and cognitive enhancement. |
| Sermorelin Geref, GRF 1-29 | Research Only | Hormonal | Moderate | Previously FDA-approved (Geref) for growth hormone deficiency diagnosis. Withdrawn from market but available through com... |
| SHLP-2 Small Humanin-Like Peptide 2, SHLP2 | Research Only | Longevity | Low | Not FDA-approved. Small humanin-like peptide 2. Early preclinical research on mitochondrial function. |
| SHLP-6 Small Humanin-Like Peptide 6, SHLP6 | Research Only | Longevity | Low | Not FDA-approved. Small humanin-like peptide 6. Early preclinical research. |
| Sigumir Cartilage cytamin, Joint peptides | Research Only | Recovery | Low | Not FDA-approved. Khavinson bioregulator peptide for cartilage and bone. Available in Russia. |
| SLU-PP-332 ERR agonist 332, Exercise mimetic compound | Research Only | Metabolic | Very-low | Not FDA-approved. ERR agonist (exercise mimetic). Early preclinical research. |
| Stamakort Gastric peptide, Stomach bioregulator | Research Only | Other | Very-low | Not FDA-approved. Khavinson bioregulator peptide for stomach tissue. Available in Russia. |
| Suprefort Pancreatic cytamin, Pancreas peptides | Research Only | Other | Very-low | Not FDA-approved. Khavinson bioregulator peptide for pancreatic tissue. Available in Russia. |
| Svetinorm Liver cytamin, Hepatic peptides | Research Only | Other | Very-low | Not FDA-approved. Khavinson bioregulator peptide for liver tissue. Available in Russia. |
| TB-500 Thymosin Beta-4 Fragment, TB4-FRAG | Research Only | Recovery | Moderate | Not FDA-approved. Synthetic fragment of thymosin beta-4. Preclinical research only. Used in veterinary and research sett... |
| Testagen Testicular peptide, Gonad peptide | Research Only | Hormonal | Low | Not FDA-approved. Khavinson bioregulator peptide for testicular tissue. Available in Russia. |
| Thymalin Thymulin, Thymic Factor | Research Only | Immune | Moderate | Not FDA-approved in US. Approved in Russia. Thymic peptide bioregulator developed by Prof. Khavinson. |
| Thymogen Glu-Trp, EW dipeptide | Research Only | Immune | Moderate | Not FDA-approved in US. Approved in Russia as immunomodulator. Synthetic thymic dipeptide. |
| Thymosin Alpha-1 Ta1, Thymalfasin | Research Only | Immune | Moderate | Not FDA-approved in US. Approved in 35+ countries (Zadaxin) for hepatitis B/C and as immune modulator. |
| Thymulin FTS, Facteur Thymique Serique | Research Only | Immune | Moderate | Not FDA-approved. Naturally occurring thymic nonapeptide. Preclinical research on immune modulation. |
| Ventfort Vascular cytamin, Blood vessel peptides | Research Only | Other | Very-low | Not FDA-approved. Khavinson bioregulator peptide for vascular tissue. Available in Russia. |
| Vesugen KED-vascular, Lys-Glu-Asp (vascular) | Research Only | Other | Low | Not FDA-approved. Khavinson bioregulator peptide for vascular tissue. Synthetic tripeptide. |
| Vilon KE, Lys-Glu | Research Only | Immune | Low | Not FDA-approved. Khavinson bioregulator peptide for immune system. Synthetic dipeptide. |
| Vladonix Thymus cytamin, Thymic peptide supplement | Research Only | Immune | Low | Not FDA-approved. Khavinson bioregulator peptide for thymus. Available in Russia. |